| Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation CL Hsieh, T Fei, Y Chen, T Li, Y Gao, X Wang, T Sun, CJ Sweeney, ... Proceedings of the National Academy of Sciences 111 (20), 7319-7324, 2014 | 396 | 2014 |
| Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer HCN Nguyen, W Xie, M Yang, CL Hsieh, S Drouin, GSM Lee, PW Kantoff The Prostate 73 (4), 346-354, 2013 | 279 | 2013 |
| ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion C Cai, CL Hsieh, J Omwancha, Z Zheng, SY Chen, JL Baert, ... Molecular endocrinology 21 (8), 1835-1846, 2007 | 133 | 2007 |
| The altered expression of MiR‐221/‐222 and MiR‐23b/‐27b is associated with the development of human castration resistant prostate cancer T Sun, M Yang, S Chen, S Balk, M Pomerantz, CL Hsieh, M Brown, ... The Prostate 72 (10), 1093-1103, 2012 | 108 | 2012 |
| c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation SY Chen, C Cai, CJ Fisher, Z Zheng, J Omwancha, CL Hsieh, ... Oncogene 25 (54), 7212-7223, 2006 | 82 | 2006 |
| Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells C Cai, J Omwancha, CL Hsieh, L Shemshedini Prostate cancer and prostatic diseases 10 (1), 39-45, 2007 | 71 | 2007 |
| PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy CL Hsieh, G Botta, S Gao, T Li, EM Van Allen, DJ Treacy, C Cai, HH He, ... Cancer research 75 (10), 1944-1948, 2015 | 56 | 2015 |
| c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer C Cai, CL Hsieh, L Shemshedini Molecular cancer research 5 (7), 725-735, 2007 | 52 | 2007 |
| Androgen receptor-mediated downregulation of microRNA-221 and-222 in castration-resistant prostate cancer B Gui, CL Hsieh, PW Kantoff, AS Kibel, L Jia PLoS One 12 (9), e0184166, 2017 | 39 | 2017 |
| Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer C Cai, CL Hsieh, S Gao, A Kannan, M Bhansali, K Govardhan, R Dutta, ... Molecular endocrinology 26 (2), 292-307, 2012 | 27 | 2012 |
| A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer S Gao, CL Hsieh, M Bhansali, A Kannan, L Shemshedini PLoS One 8 (5), e64189, 2013 | 22 | 2013 |
| Small molecule and pooled CRISPR screens investigating IL17 signaling identify BRD2 as a novel contributor to keratinocyte inflammatory responses PF Slivka, CL Hsieh, A Lipovsky, SD Pratt, J Locklear, MT Namovic, ... ACS Chemical Biology 14 (5), 857-872, 2019 | 19 | 2019 |
| Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells CL Hsieh, C Cai, A Giwa, A Bivins, SY Chen, D Sabry, K Govardhan, ... Journal of Molecular Endocrinology 41 (1), 13-24, 2008 | 18 | 2008 |
| Zinc finger 280B regulates sGCα1 and p53 in prostate cancer cells S Gao, CL Hsieh, J Zhou, L Shemshedini PloS one 8 (11), e78766, 2013 | 16 | 2013 |
| Enhancer RNAs mediate estrogen-induced decommissioning of selective enhancers by recruiting ERα and its cofactor M Yang, JH Lee, Z Zhang, R De La Rosa, M Bi, Y Tan, Y Liao, J Hong, ... Cell reports 31 (12), 2020 | 15 | 2020 |
| Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells J Zhou, S Gao, CL Hsieh, M Malla, L Shemshedini PLoS One 12 (8), e0184088, 2017 | 6 | 2017 |
| Treatment of cancers with A-8R peptide L Shemshedini, SY Chen, C Cai, CL Hsieh US Patent 8,575,087, 2013 | 4 | 2013 |
| Compositions of A-8R peptide L Shemshedini, SY Chen, C Cai, CL Hsieh US Patent 9,393,254, 2016 | 3 | 2016 |
| Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells K Barlan, GP Bhide, DR White, MR Lake, C Lu, SE Rieder, L Fan, ... SLAS Discovery 29 (1), 52-58, 2024 | | 2024 |
| Compositions and Methods of Treatment of Cancers L Shemshedini, SY Chen, C Cai, CL Hsieh US Patent App. 15/374,640, 2017 | | 2017 |
